aap Implantate AG (STU:AAQ1) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AAQ1 aap Implantate AG STU:AAQ1
54 GF Score
Price €1.68
GF Value €1.29
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is aap Implantate AG Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


aap Implantate AG  (STU:AAQ1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


aap Implantate AG Cyclically Adjusted PS Ratio Related Terms


aap Implantate AG Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for aap Implantate AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aap Implantate AG Cyclically Adjusted PS Ratio Chart

aap Implantate AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.31 0.23 0.39 0.45

aap Implantate AG Semi-Annual Data
Jun14 Dec14 Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.39 0.49 0.45 0.62

STU:AAQ1 vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, aap Implantate AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's Cyclically Adjusted PS Ratio falls into.


STU:AAQ1
54GF Score
aap Implantate AG STU:AAQ1
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aap Implantate AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

aap Implantate AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 is calculated as:

For example, aap Implantate AG's adjusted Revenue per Share data for the fiscal year that ended in Dec25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=1.216/129.3606*129.3606
=1.216

Current CPI (Dec25) = 129.3606.

aap Implantate AG Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 3.065 101.217 3.917
201712 3.443 102.617 4.340
201812 3.397 104.217 4.217
201912 3.374 105.818 4.125
202012 2.680 105.518 3.286
202112 2.475 110.384 2.901
202212 1.934 119.345 2.096
202312 1.384 123.773 1.446
202412 1.187 127.041 1.209
202512 1.216 129.361 1.216

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is aap Implantate AG (STU:AAQ1) Overvalued in 2026?

Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued. The current stock price of €1.68 is trading 30.2% above its estimated GF Value™ of €1.29. GuruFocus considers aap Implantate AG to be Modestly Overvalued.

Key valuation signals for STU:AAQ1:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €1.29 vs. price of €1.68 (30.2% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the STU:AAQ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aap Implantate AG Business Description

Other Exchanges 0N5A:UKAAQ1:Germany
Address Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
54GF Score

Get the complete analysis for STU:AAQ1

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.68
Price
€1.29
GF Value